dockets: FDA-2005-P-0194
This data as json
| id | agency_id | title | docket_type | last_modified | object_id |
|---|---|---|---|---|---|
| FDA-2005-P-0194 | FDA | Evaluation of the Adequacy of Warnings to Patient-Consumers that Psychosis Is a Possible Adverse effect of Keppra (levetiracetam) - CLOSED | Nonrulemaking | 2021-09-01T01:01:17Z | 0b00006480440ea4 |
Links from other tables
- 12 rows from docket_id in documents